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  Hydrogen Sulfide (H2S) prevents and treats a variety of disorders via its cytoprotective 
effects. However, the effects of H2S on rats with cisplatin (CP) nephrotoxicity are unclear. The 
aim was to study the effects of H2S on rats with CP nephrotoxicity. Thirty male Sprague-Dawley 
rats were divided into three groups: control group, nephrotoxic group received single dose of 
CP (6 mg kg-1) and nephrotoxic groups that received single dose 100 µmol kg-1 NaHS. On fifth 
day after injection, urine of each rat was collected over a 24-hr period. Animals were sacrificed 
6 days after CP (or vehicle) treatment, and blood, urine, and kidneys were obtained, prepared 
for light microscopy evaluation, lipid peroxidation content and laboratory analysis. The results 
showed that plasma urea (226%), creatinine (271%), renal lipid peroxidation content (151%), 
Na and K fractional excretion, urine protein, volume and kidney weight in CP nephrotoxic rats 
were significantly higher and urine osmolarity and creatinine clearance lower than in controls. 
Increases of the proximal tubular cells apoptosis and mesangial matrix in CP nephrotoxicity 
group  rats  were  observed.  Hydrogen  sulfide  reversed  the  CP-induced  changes  in  the 
experimental rats H2S prevented the progression of CP nephrotoxicity in rats possibly through 
its cytoprotective effects such as antioxidant properties.  
© 2014 Urmia University. All rights reserved. 
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سیس زا ׌شان ׌ویل֩ تیمومسم رد ار هیل֩ ׌تفاب بیسآ و ׌در֩لمع صقن نژوردیه دیفلوس ׌م دوبهب نیتلاپ دشخب  
 هدی֩چ  
ش׌پ رد ׌لولس تظفاحم رثا ندوب ارادرطاخ هب ن֘ورد׌ه د׌فلوس ׌م هدافتسا ׌دا׌ز تلالاتخا نامرد و ׌ر׌گ س׌س زا ׌شان ׌و׌لک ت׌مومسم رب ن֘ورد׌ه د׌فلوس رثا .دوش لاپ ׌م صخشمان ن׌ت  دشاب
 هعلاطم ن׌ا رد .تسا ׌ن׌تلاپ س׌س ׌و׌لک ت׌مومسم رد نآ تارثا ׌سررب هعلاطم ن׌ا فده هک 03    هب ׌׌ارحص شوم رس هس   ׌و׌لک ت׌سمومسم ،لرتنک :هورگ    ن׌تلاپ س׌س اب ( 6    )مرگول׌ک رب مرگ ׌ل׌م
( ن֘ورد׌ه د׌فلوس اب هدش نامرد ׌و׌لک ت׌مومسم و 033   رگول׌ک رب مرگ ׌ل׌م زا دعب زور جنپ .دندش م׌سقت ،)م   هنومن ،تاق׌رزت ماجنا  راردا ׌ 42   هنومن ،هتعاس هنومن و نوخ ׌ ׌   ه׌لک تفاب    و ׌روآ عمج
راردا مجح ،راردا ن׌ئتورپ ،ه׌لک ׌برچ نو׌ساد׌سکارپ ׌اوتحم ،م׌ساتپ و م׌دس ׌عفد رسک ،ن׌ن׌تارک ،هروا هک داد ناشن ج׌اتن .دندش ׌سررب   ه׌لک نزو و هب اه    ׌و׌لک ت׌مومسم هورگ رد ׌راد ׌نعم روط
س׌س هت׌رلاومسا و رتلااب ׌ن׌تلاپ ن׌׌اپ ن׌ن׌تارک سنار׌لک و راردا ׌ س׌س ׌و׌لک ت׌مومسم رد زوتپوپآ .دوب لرتنک هورگ زا رت   هدنهد اب نامرد .دوب لرتنک هورگ زا رتش׌ب ׌ن׌تلاپ  ن֘ورد׌ه د׌فلوس ׌
׌نعم تروص هب ار تار׌׌غت ن׌ا تسناوت اد س׌س ׌و׌لک ت׌مومسم تفرش׌پ زا ׌ناد׌سکا ׌تنآ صاوخ ل׌بق زا دوخ ׌لولس تظفاحم تارثا اب لاامتحا ن֘ورد׌ه د׌فلوس هج׌تن رد .دنادرگرب ׌ر  ׌ن׌تلاپ
׌م ׌ر׌گولج .دنک  
:׌دیل֩ ׌اه هژاو    ،زوتپوپآ س׌س ،ن֘ورد׌ه د׌فلوس ،ن׌تلاپ    ׌و׌لک ت׌مومسم  
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Introduction 
 
Cisplatin  (cis-diamminedichloroplatinum  II,  CP)  is  a 
potent  anticancer  drug  commonly  used  against  cancers, 
including testicular, cervical, head and neck malignancies. 
The drug is also known to produce a number of toxicities 
in kidney, gastrointestinal tract and nervous system.1-3 The 
drug is bio-activated to a nephrotoxicant,4 and it damages 
cell  mitochondria  altering  the  cellular  transport  system 
and  eventually  causes  apoptosis,  inflammation,  necrosis 
and  death  in  cells.5,6  The  limiting  factor  of  CP  is  its 
progressive  irreversible  nephrotoxicity.7  This  has  been 
ascribed to several mechanisms such as oxidative stress,8,9 
modulation of nitric oxide,10 and modulation of adenosine.11  
Hydrogen sulfide (H2S) is an endogenously produced 
gaseous signaling molecule with diverse physiological effects. 
Its production in mammalian systems has been attributed 
to  two  key  enzymes  in  cysteine  biosynthesis  pathway, 
cystathionine β-synthase (CBS) and cystathionine γ-lyase. 
The rate of H2S production in tissue is in the range of 1 to 
10 pmol sec-1 per mg protein, resulting in low micromolar 
extracellular concentrations.12,13 It is at these physiological 
concentrations that H2S is cytoprotective in various models 
of cellular injury.14,15 The cytoprotective effects of H2S are 
partially related to its ability to neutralize reactive oxygen 
species (ROS), promoting vascular smooth muscle relaxation, 
reducing  apoptotic  signaling,  and  reversibly  modulating 
mitochondrial respiration.16 Many studies suggest exogenous 
and endogenous H2S is protective against renal ischemia-
reperfusion injury. Topical administration of NaHS on kidneys 
plays a key role in protecting against renal ischemia and 
renal function can be improved.17,18 During ischemia, H2S 
levels  drop  along  with  kidney  function.19  Main  enzyme 
responsible for H2S production in kidney is CBS that its 
inhibition  leads  to  accumulation  of  homocysteine  and 
worsening  renal  ischemia-reperfusion  injury.20  Another 
study has showed inhibition of generation of endogenous 
H2S with DL-propargylglycine an inhibitor of endogenous 
H2S formation, has improved CP-induced renal damage.21 
But the generation of endogenous H2S may either limit or 
contribute to the degree of tissue injury caused by ischemia-
reperfusion and chronic kidney disease.18,22 To clear up these 
controversies, we aimed to investigate the role of H2S and 
its potential beneficiary effects in relation to physiological, 
biochemical, and histological changes induced by CP in rats. 
 
Materials and Methods 
 
Animals.  Thirty  male  Sprague-Dawley  rats  weighing 
180 to 220 g were purchased from animal house center of 
Ahvaz Jundishapur University of Medical Science, Ahvaz, 
Iran.  All  animals  were  housed  in  cages  with  12/12  hr 
light/dark cycle at 22 ± 2 ˚C. All experimental procedures were 
performed according to Ahvaz University Ethical Committee 
for care and use of laboratory animals. 
  Chemicals. Cisplatin, other chemicals and reagents were 
obtained from Sigma Aldrich chemical Co. (St. Louis, USA). 
Experimental  design.  Thirty  rats  were  divided  into 
three groups of 10 rats per each group. The groups were 
divided as follows; control group, untreated CP  nephro-
toxicity  group  (6  mg  kg-1,  intraperitoneally),  and  CP 
nephrotoxicity  group  treated  with  intraperitoneal  NaHS 
(100 µmol kg-1, 1 hr before CP injection). The doses of NaHS 
were selected based on the findings from previous study 
that examine renal ischemia-reperfusion injury in the rat.18 
At  the  5th  day,  rats  were  kept  individually  in  metabolic 
cage with access to drinking water for measurement of 
24 hr urinary protein and urine volume. At the end of the 
experimental, 10 rats from each group were sacrificed by 
intraperitoneal overdose of xylazine (30 mg kg-1, Alfasan, 
Woerden,  The  Netherlands)  and ketamine (120  mg  kg-1, 
Alfasan, Woerden, The Netherlands). The right kidneys were 
harvested stored in 10% neutral formalin and was fixed 
separately for light microscopy evaluation. In addition, the 
left kidney was dissected and rinsed with isotonic saline 
and then blotted dry and weighed. Then, the kidney tissue 
was minced and homogenized with 5% (w/v) potassium 
phosphate  buffer  (0.1  M,  pH  7.4)  using  a  homogenizer 
(Heidolph Silent crusher-M, Donau, Germany). Homogenate 
was  then  centrifuged  at  10000  g  for  5  min  to  remove 
nuclei and cell debris. This supernatant was used for the 
measurement of lipid peroxidation. 
Biochemical Analysis. One day before the rats were 
killed, urine of each rat was collected over a 24 hr period 
and the volume was measured. All rats were killed 6 days 
after CP administration. Blood was collected from heart 
in tubes and immediately centrifuged at 3000 g at 5 ˚C for 
10  min  to  separate  plasma.  The  plasma  obtained  was 
stored  frozen  at  –20  ˚C  to  await  biochemical  analyses. 
Kidneys were removed from the rats, washed with ice-
cold  saline,  blotted  with  a  piece  of  filter  paper  and 
weighed. The cortex of left kidney was excised from the 
medulla, and rapidly homogenized in ice-cold potassium 
phosphate buffer to produce 1:10 (w/v) tissue homogenate. 
Urine  osmolality  was  measured  by  the  freezing  point 
depression  method  (–70  ˚C)  using  an  osmometer 
(Hermann  Roebling,  Berlin,  Germany),  urine  protein 
concentration  was  measured  by  a  trichloroacetic  acid 
(TCA) precipitation method. Trichloroacetic acid method 
measures the turbidity at 420 nm when a 50 µL sample is 
mixed with 150 μL of 30 g L-1 TCA at 25 ˚C.23 Urinary 
BUN,  creatinine,  Na  and  K  were  measured  by  auto 
analyzer (Model BT3000; Biotechnica, Rome, Italy). 
Renal  histology.  After  fixation  of the  kidneys  with 
10% formalin, renal tissues were sectioned and stained 
with periodic acid-Schiff (PAS) reagents for histological 
examination.  Tubular  damage  in  PAS-stained  sections 
was examined under the microscope (×200 magnification) 
and scored based on the percentage of cortical tubules 
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to 25%; 3 = 26 to 75%; and 4 = 75%. Tubular necrosis was 
defined as the loss of the proximal tubular brush border, 
blobbing  of  apical  membranes,  tubular  epithelial  cell 
detachment  from  the  basement  membrane,  or  intra-
luminal aggregation of cells and proteins. 
TUNEL staining. DNA fragmentation was labeled in 
situ  using  an  in  situ  cell  death  detection  kit  (Roche 
Diagnostics,  Mannheim,  Germany).  Paraffin-embedded 
tissues  were  cut  into  5  µm  thick  sections,  and  after 
deparaffinization and dehydration  were digested with 
proteinase  K  and  treated  according  to  the  protocol 
provided  with  the  kit.  According  to  TUNEL-reaction 
bases,  labeled  nucleotides  were  catalytically  added  to 
3’-OH ends of DNA by terminal deoxynucleotidyl trans-
ferase  in  a  template-independent  manner.  Sections 
were  then  reacted  with  anti-fluorescein  antibody 
conjugated with horse radish peroxidase as a reporter 
enzyme.  In  situ  cell  death  detection  kit  provides 
diaminobenzidine to produce a brown reaction product 
that marks the nuclei of apoptotic cells. Sections were 
counterstained  with  hematoxylin.  Apoptosis  positive 
cells were evaluated by light microscope. The number 
of  apoptotic  cells  in  each  section  was  calculated  by 
counting the number of TUNEL positive apoptotic cells 
in 10 × 400 fields per slide. 
Estimation of lipid peroxidation. Lipid peroxidation 
in  kidney  tissue  homogenate  of  all  the  experimental 
animals  was  determined  for  thiobarbituric  acid  reactive 
substances  (TBARS)  formation.24  Amount  of  500  μL  of 
supernatant was mixed with 1.5 mL of 10% trichloroacetic 
acid. After centrifugation (3000 g for 15 min), 1.5 mL of 
supernatant was added to 2 mL of 0.67% thiobarbituric 
acid and heated for 30 min at 100 ˚C. After cooling, the 
sample  was  extracted  with  2  mL  of  n-butanol.  After 
centrifugation at 3000 g for 15 min the organic phase was 
collected  and  the  absorbance  was  read  spectrophoto-
metrically  at  535  nm  using  a  blank  containing  all  the 
reagents  except  the  tissue  homogenate.  Values  were 
expressed as nmol g-1 kidney tissue. As 99% of TBARS is 
malondialdehyde  (MDA),  TBARS  concentrations  of  the 
samples were calculated from a standard curve using 1, 1, 
3, and 3- tetramethoxypropane. 
Statistical analysis. Data were analyzed using one-
way ANOVA and followed by Tukey’s test in SPSS (Version 
16; SPSS Inc., Chicago, USA). Data are expressed as mean 
±  SEM.  A  p  value  less  than  0.05  was  considered  as 
statistically significant differences. 
  Results 
 
Effects  of  NaHS  on  kidney  weight  percentage. 
Rats given CP lost their initial body weight, while NaHS-
treated rats gained their initial body weight. In the CP 
nephrotoxic group, kidneys’ weight increased significantly 
compared to control rats (p < 0.01). After administration 
of  NaHS,  a  significant  decrease  of  kidney  weight  was 
found in treated CP nephrotoxic group in comparison to 
CP nephrotoxic group (p < 0.05), (Table 1). 
Effects of NaHS on plasma and urine biochemical 
analysis.  Tables  2  and  3  show  the  effects  of  treatment 
with  saline,  CP,  and  NaHS  on  concentrations  of  plasma 
urea, creatinine, Na, K and Urinalysis. Cisplatin significantly 
increased  the  concentrations  of  plasma  urea  and 
creatinine (p < 0.01). Compared with saline-treated rats, 
CP increased daily urine volume, while, NaHS treatments 
decreased urine volume (p < 0.01). Urine osmolality in CP-
treated  rats  decreased  compared  with  saline-treated 
controls (p < 0.01). In NaHS-treated rats, urine osmolality 
increased significantly in comparison with CP treated rats 
(p < 0.05). Urine protein excretion increased in CP-treated 
rats  and  NaHS  treatment  significantly  decreased  urine 
protein excretion (p < 0.01).  
 
 
 
 
 
 
 
 
 
 
Effects of NaHS on kidney and tubular functions. 
Table  4  shows  the  effects  of  CP  and  NaHS  on  the 
creatinine clearance, Na and K fractional excretion. In CP 
treated  rats  creatinine  clearance  decreased (p < 0.01) 
and  fractional  excretion of  Na and  K was increased 
(p < 0.01). Effects of CP on kidney and tubular functions 
were reversed by NaHS treatment.  
Effects of NaHS on renal lipid peroxidation content. 
The renal lipid peroxidation content in CP nephrotoxic rats 
was significantly higher compared to control rats (Fig. 1). 
NaHS administration resulted in a significantly lower renal 
lipid  peroxidase  content  compared  to  the  untreated  CP 
nephrotoxic rats. 
 
 
 
 
 
 
 
 
 
 
Table 1. Effect of CP and treatment with NaHS on weight of body and kidneys of rats, (n = 10).  
Groups  Initial weight (g)  Final weight (g)  Change (%)  Kidneys’ weight (g)  Kidneys’ weight (%) 
Controls  221.50 ± 4.80  227.40 ± 5.10   5.90 ± 0.30  1.82 ± 0.10  0.80 ± 0.02 
CP  201.30 ± 6.20  196.30 ± 5.80   -5.00 ± 0.50*  1.83 ± 0.10    0.93 ± 0.06* 
CP + NaHS  216.70 ± 3.80  218.60 ± 3.80      1.90 ± 0.20*†  1.81 ± 0.20    0.82 ± 0.07† 
Values are significantly different (*compared to control, and † compared to cisplatin group; p < 0.01).  
Either Cisplatin (6 mg kg-1) or NaHS (100 µg kg-1) was given first day. Rats were weighed before any injection and in the 5th day, 
then sacrificed. 
Table  2.  Plasma  creatinine,  urea,  and  sodium  and  potassium 
concentrations of each group, (n = 10). 
Groups 
Creatinine 
(mg dL-1) 
Urea 
(mg dL-1) 
Na 
(mEq L-1) 
K 
(mEq L-1) 
Controls  0.46 ± 0.03  32.10 ± 2.00  145.00 ± 1.40  4.54 ± 0.12 
CP    1.25 ± 0.09*    72.82 ± 3.40*  143.00 ± 1.40  5.57 ± 0.13* 
CP + NaHS  0.59 ± 0.05†    51.30 ± 1.80*† 144.00 ± 0.90  5.23 ± 0.10* 
Values are significantly different (*compared to control, and † 
compared to cisplatin group; p < 0.01) within the same column. 
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Effects of NaHS on renal histology and apoptosis 
in  CP  nephrotoxic  rats.  A  moderate  increase  of 
mesangial  matrix  in  the  glomeruli  of  most  CP 
nephrotoxic rats in comparison to the control rats has 
been shown in Fig. 2. This was evident by an increase in 
PAS-positive  mesangial  matrix  area.  Treatment  with 
NaHS  reversed  the  mesangial  matrix  accumulation 
caused CP. Figure 3 shows the apoptosis in the tubular 
epithelial  cells  in  CP  group.  Apoptotic  cells  were  not 
observed  in  tubular  cells  in  the  control  rats.  The 
apoptotic  cells  decreased  in  NaHS-treated  CP  group 
when compared to untreated CP rats. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. Malondialdehyde concentration as a marker for renal level 
of lipid peroxidation. (* indicates significant difference compared 
to control, and † compared to cisplatin group; p < 0.01), (n=10). 
 
 
 
  Discussion  
 
Cisplatin  is  an  effective  chemotherapeutic  agent  for 
treating various solid tumors. The main limitation of this 
drug is nephrotoxicity.25,26 The reduction in body weight 
following CP treatment may possibly be due to the injured 
renal tubules, and the subsequent loss of the tubular cells 
to reabsorb water leading to dehydration and loss of body 
weight.  The  increased  urine  volume  might  also  be  the 
reason  behind  the  loss  of  body  weight.  Treatment  with 
NaHS antagonized this event significantly, but not completely. 
This  improvement  of  the  CP-induced  body  weight 
reduction is an evidence of the general palliative effect of 
NaHS  on  the  nephrotoxicity.  Further  support  for  the 
salutatory action on the renal function was obtained from 
the improvement of the increase in plasma concentrations 
of  creatinine  and  urea.  The  urine  analysis  in  this  work 
confirmed that CP caused a polyuric acute renal failure, as 
judged by significant increases in the volume of urine, and 
urine  protein  excretion  concomitant  with  a  significant 
decrease  in  osmolality.  Treatment  with  NaHS  reversed 
significantly effects induced by CP, albeit not completely. 
Therefore this cytoprotective and antioxidant agent could 
ameliorate CP nephrotoxicity. The extensive necrosis and 
apoptosis of the renal tissues seen in the slides of kidneys 
in rats treated with CP were reduced by pretreatment with 
NaHS.  This  is  in  line  with  the  biochemical  changes 
observed  in  serum  and  urine.  Although  the  nephro-
protective  mechanism  of  NaHS  is  not  well  understood, 
there is evidence that NaHS has a strong antioxidant effect 
in several organs.27,28 Formation of reactive oxygen species 
in kidney plays an important role in CP-induced nephro-
toxicity,29,30 and several antioxidants and thiol compounds 
have been shown to protect against CP nephrotoxicity.29,31 
 
 
Table 3. Effect of CP and NaHS on urinalyses, (n = 10). 
Groups 
Urine output 
(mL 24 hr) 
Urine protein  
(g 100 mL-1) 
Urine Osmolality 
(osmole) 
Controls   8.00 ± 0.40  5.50 ± 0.20  2053.40 ± 78.00      
CP  10.95 ± 0.30*     8.90 ± 0. 30*    1381.70 ± 76.00* 
CP + NaHS    8.75 ± 0.50†    8.75 ± 0.50†     1691.20 ± 60.00*† 
Values are significantly different (*compared to control, and † 
compared to cisplatin group; p < 0.01) within the same column. 
Table 4. Effect of CP and NaHS on kidney and tubular functions, (n = 10). 
Groups 
Creatinine clearance  
(mL min-1) 
creatinine clearance  
(mL min-1 per gram of kidney tissue) 
Fractional excretion 
of sodium  
Fractional excretion  
of potassium  
Controls  0.89 ± 0.06  0.48 ± 0.03  0.86 ± 0.03  10.32 ± 0.30 
CP    0.47 ± 0.06*    0.25 ± 0.02*    2.69 ± 0.20*    23.92 ± 1.90* 
CP + NaHS    0.77 ± 0.05†    0.43 ± 0.04†    1.15 ± 0.09†   12.56 ± 1.10† 
Values are significantly different (*compared to control, and † compared to cisplatin group; p < 0.01) within the same column. 
Fig. 2. Photomicrographs of renal tissues by in situ cell death detection kit. NaHS attenuates the cisplatin-induced histopathological 
damage. (A) Control group; (B) cisplatin nephrotoxic group; (C) cisplatin nephrotoxic group treated with NaHS. Arrows show TUNEL 
positive cells, (TUNEL staining, 400×).  
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The  present  work  confirms  that  CP  raise  the  lipid 
peroxidation leaving the renal tissues vulnerable to damage 
by oxygen radicals responsible for tubular epithelial cell 
death. The present data show that pre-treatment of rats 
with  the  antioxidant  agent  NaHS  decreased  MDA  as  a 
marker for lipid peroxidation. These actions may have led 
to  the amelioration  of  the  histological, serum and  urine 
biochemical indices of renal damage. Several studies have 
suggested that ROS may be second messengers in nuclear 
factor (NF-kB) activation and that antioxidants suppress 
NF-kB activation.31,32 NaHS has recently been reported to 
indirectly suppress NF-kB activation induced by ROS, and 
subsequently  inhibits  the  transcription  of  a  variety  of 
inflammatory genes in renal ischemia-reperfusion Injury.18 
The  H2S-donor,  NaHS  reduces  the  renal  injury  and 
dysfunction caused by CP in rats. This study investigates 
the  effects of  H2S-donor NaHS  on injury,  renal  function, 
glomerular  function,  and  tubular  function.  High  sodium 
and  potassium  fractional  excretion  indicates  impaired 
reabsorptive  function  in  CP-induced  nephrotoxicity.  In 
addition to the amelioration of renal dysfunction (plasma 
BUN and creatinine), administration of NaHS (1 hr before 
CP administration) has mitigated renal injury (histology), 
glomerular dysfunction (creatinine clearance), and tubular 
dysfunction (fractional excretion of sodium and potassium) 
caused by CP. At least two pathophysiological mechanisms 
lead  to  tubular  cell  death  in  CP  nephro-toxicity.33,34 
Necrosis is characterized by loss of membrane integrity, 
cellular  fragmentation,  and  an  inflammatory  response. 
Apoptosis  is  characterized  by  cytoplasmic  and  nuclear 
shrinkage, DNA fragmentation, and breakdown of the cell 
into apoptotic bodies. Apoptosis is the major mechanism 
of early tubular cell death in acute kidney injury.18,34 It has 
been reported that H2S exhibit pro-inflammatory activities 
in endotoxic shock endotoxemia.35-37  H2S  also  has  potent 
anti-inflammatory effects. For instance, the H2S donor (S-
diclofenac)  down-regulates  the  expression  of  inducible 
nitric oxide synthase, cyclooxygenase type II, cystathionine 
gamma-lyase (CGL), and nuclear factor κB in a rat model of 
endotoxic  shock.38  Another  H2S  donor  (NaHS)  has  been 
reported to exhibit gastro-protective effect against mucosal 
lesions induced by ischemia-reperfusion injury.39 It is known 
   
 
 
 
 
 
 
 
 
 
 
 
 
that ROS and lipid peroxidation play a role in CP induced 
cellular damage in kidney’s tubular epithelium40 Various 
treatments have been evaluated to reduce nephrotoxicity 
caused  by  CP.41,42  Histopathological  examination  of  rat 
kidney  was  carried  out  to  determine  the  number  of 
apoptotic  cells  and  cortical  proximal  tubular  necrosis 
score.  The  number  of  apoptotic  cells  and  proximal 
tubular necrosis score were statistically low in the CP + 
NaHS  group  which  showed  that  NaHS  treatment 
significantly reduced histopathological damage caused by 
CP in the kidneys. 
In conclusion, we have shown that the pretreatment 
with NaHS could mitigate some signs of CP nephrotoxicity 
in rats. Further pharmacological and toxicological studies 
are needed to confirm NaHS safety and its efficacy against 
CP  nephrotoxicity.  It  can  be  concluded  that  NaHS  is  a 
potentially nephroprotectant both in animals and humans.  
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